Cormorant Asset Management, LP Tricida, Inc. Transaction History

Cormorant Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $1.52 Million - $1.99 Million	-427,975 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.37 - $9.46 $1.31 Million - $2.84 Million	-300,000 Reduced 41.21%	427,975 $3.02 Million
Q3 2020 Nov 16, 2020	SELL	$8.56 - $26.93 $1.23 Million - $3.88 Million	-144,162 Reduced 16.53%	727,975 $6.6 Million
Q2 2020 Aug 14, 2020	SELL	$21.21 - $31.55 $123,823 - $184,188	-5,838 Reduced 0.66%	872,137 $24 Million
Q1 2020 May 15, 2020	SELL	$18.43 - $38.04 $921,500 - $1.9 Million	-50,000 Reduced 5.39%	877,975 $19.3 Million
Q4 2019 Feb 14, 2020	SELL	$29.6 - $43.71 $4.59 Million - $6.77 Million	-154,905 Reduced 14.3%	927,975 $35 Million
Q3 2019 Nov 14, 2019	SELL	$29.87 - $42.22 $2.84 Million - $4.01 Million	-95,095 Reduced 8.07%	1,082,880 $33.4 Million
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $5.25 Million - $6.64 Million	168,389 Added 16.68%	1,177,975 $46.5 Million
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $5.55 Million - $10.7 Million	277,965 Added 37.99%	1,009,586 $39 Million
Q4 2018 Feb 14, 2019	SELL	$23.57 - $32.33 $69,932 - $95,923	-2,967 Reduced 0.4%	731,621 $17.3 Million
Q3 2018 Nov 14, 2018	SELL	$22.5 - $39.35 $4.5 Million - $7.87 Million	-200,000 Reduced 21.4%	734,588 $22.4 Million
Q2 2018 Aug 14, 2018	BUY	$26.0 - $29.9 $24.3 Million - $27.9 Million	934,588 New	934,588 $27.9 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.